Manufacturing, Vaccines

Drug Solutions Podcast: mRNA Past, Present, and Future

August 17, 2023

An mRNA conversation about the recent past, current hot topics, and probable future.

Charting the Future of Vaccines

August 03, 2023

A comprehensive understanding of what makes mRNA vaccines tick is crucial in charting the future of the market.

Drug Solutions Podcast: Evaluating the Vaccine Marketplace

July 18, 2023

Jeff Fischer, co-founder and president of Longhorn Vaccines and Diagnostics, discusses the history and ongoing development of both protein- and mRNA-based vaccines.

Croda Pharma Breaks Ground on Excipients Manufacturing Facility

June 14, 2023

The new excipients manufacturing facility is expected to be completed in 2025.

invoX Pharma Invests in pHion Therapeutics to Develop Next-Generation mRNA Vaccines

June 06, 2023

invoX Pharma has made a second tranche of investment in pHion Therapeutics to support further development of next-generation mRNA vaccines.

Vaccine Nationalism Escalating Risk

June 02, 2023

Vaccine nationalism strengthens viruses and poses deadly risks for all involved.

Exploring Foreign Epitopes Recogniton in Personalized Medicines with Vibha Jawa

May 04, 2023

Vibha Jawa, executive director at Bristol Myers Squibb, discusses foreign epitopes recognition from what should be fully human antibody therapies.

Vaccine Development Builds on COVID-19 Breakthroughs

March 02, 2023

Advances in vaccine development are creating partnerships and stimulating clinical trials to develop new mRNA applications.

Recipharm: Combatting Future Viral Threats with Vaccine Advances

February 07, 2023

The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.

Combatting Future Viral Threats with Vaccine Advances

February 03, 2023

The COVID-19 pandemic has led to many changes and shifts in the pharmaceutical industry, specifically with how pharmaceutical companies develop vaccines.